Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levels

被引:12
|
作者
Stucki, M
Schnorf, J
Hustinx, H
Gerber, H
Lerch, PG
Halabi, A
Kleinbloesem, CH
Morell, A
机构
[1] Swiss Red Cross, Blood Transfus Serv, ZLB Cent Lab, CH-3000 Bern 22, Switzerland
[2] Clin Pharma Res AG, Birsfelden, Switzerland
关键词
anti-D; pharmacodynamics; pharmacokinetics; prophylaxis; Rh(D) immunization;
D O I
10.1016/S1246-7820(98)80409-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Properties of a new anti-D immunoglobulin were assessed in Rh(D) negative healthy male adults. Six volunteers received intravenous, and five volunteers intramuscular injections of 200 mu g anti-D, 48 hours after pre-treatment with 5 mL of Rh(D) positive erythrocytes. Immediately after intravenous administration of anti-D, a rapid decrease of the Rh(D) positive erythrocytes was noted. After intramuscular injection of anti-D, there was a lag phase of 6 hours until the erythrocytes decreased, and the elimination rate was slower. Twenty-four hours after injection of anti-D, the Rh(D) positive erythrocytes were at the detection limit or no longer detectable in all volunteers. After intravenous administration, anti-D serum levels decreased from 45 ng/mL at two hours to 29 ng/mL at 24 hours, whereas after intramuscular administration, anti-D became detectable at 4 hours and increased to 11 ng/mL at 24 hours. During subsequent months, anti-D serum levels decreased at similar rates in both groups. After six months, anti-D was not detectable in any of the volunteers. Thus, the new anti-D immunoglobulin induced elimination of the Rh(D) positive erythrocytes and suggested that Rh(D) immunization of the volunteers was prevented. (C) Elsevier 1998, Paris.
引用
收藏
页码:180 / 188
页数:9
相关论文
共 50 条
  • [21] Pharmacokinetics (PK) of S/D treated anti-D immunoglobulin after intramuscular injection in healthy volunteers: gender differences in PK
    Jilma-Stohlawetz, P
    Reiter, RA
    Panzer, S
    Horvath, M
    Eppel, W
    Jilma, B
    TRANSFUSION AND APHERESIS SCIENCE, 2005, 33 (02) : 135 - 140
  • [22] Real-world experience of anti-D immunoglobulin in immune thrombocytopenia
    Kundan Mishra
    Suman Kumar
    Kanwaljeet Singh
    Aditya Jandial
    Rajeev Sandal
    Kamal Kant Sahu
    Sanjeev Khera
    Rajiv Kumar
    Rajan Kapoor
    Sanjeevan Sharma
    Jasjit Singh
    Satyaranjan Das
    Tathagat Chatterjee
    Ajay Sharma
    Velu Nair
    Annals of Hematology, 2022, 101 : 1173 - 1179
  • [23] Validation of flow cytometry to quantify the potency of anti-D immunoglobulin preparations
    Schäffner, G
    Kayser, T
    Tönjes, A
    Volkers, P
    VOX SANGUINIS, 2003, 84 (02) : 129 - 136
  • [24] Real-world experience of anti-D immunoglobulin in immune thrombocytopenia
    Mishra, Kundan
    Kumar, Suman
    Singh, Kanwaljeet
    Jandial, Aditya
    Sandal, Rajeev
    Sahu, Kamal Kant
    Khera, Sanjeev
    Kumar, Rajiv
    Kapoor, Rajan
    Sharma, Sanjeevan
    Singh, Jasjit
    Das, Satyaranjan
    Chatterjee, Tathagat
    Sharma, Ajay
    Nair, Velu
    ANNALS OF HEMATOLOGY, 2022, 101 (06) : 1173 - 1179
  • [25] Low frequency of anti-D alloimmunization following D plus platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study
    Cid, Joan
    Lozano, Miguel
    Ziman, Alyssa
    West, Kamille A.
    O'Brien, Kerry L.
    Murphy, Michael F.
    Wendel, Silvano
    Vazquez, Alejandro
    Ortin, Xavier
    Hervig, Tor A.
    Delaney, Meghan
    Flegel, Willy A.
    Yazer, Mark H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (04) : 598 - 603
  • [26] Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: A systematic review and meta-analysis
    Ji, Yanli
    Luo, Guangping
    Fu, Yongshui
    VOX SANGUINIS, 2022, 117 (05) : 633 - 640
  • [27] Mechanism of action of IVIG and anti-D in ITP
    Lazarus, AH
    Crow, AR
    TRANSFUSION AND APHERESIS SCIENCE, 2003, 28 (03) : 249 - 255
  • [28] Intravenous anti-D immunoglobulin in the treatment of resistant immune thrombocytopenic purpura in pregnancy
    Sieunarine, K.
    Shapiro, S.
    Al Obaidi, M. J.
    Girling, J.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (04) : 505 - 507
  • [29] Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura
    Ramadan, KMA
    El-Agnaf, M
    CLINICAL AND LABORATORY HAEMATOLOGY, 2005, 27 (04): : 267 - 269
  • [30] International collaborative study to evaluate methods for quantification of anti-D in immunoglobulin preparations
    Thorpe, SJ
    Sands, D
    Rautmann, G
    Schäffner, G
    VOX SANGUINIS, 2002, 83 (01) : 42 - 50